Glucose-responsive insulin and glucagon delivery – artificial pancreas

Dual-hormone, closed-loop delivery guided by advanced algorithms improved short-term glucose control and reduced the risk of hypoglycemia in a group of 15 adults with type 1 diabetes (Canadian Medical Association Journal)